Clinical Trials Directory

Trials / Completed

CompletedNCT04257799

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test a new surgical imaging system called "Structured Light Imaging (SLI)." This system is designed to examine tissue removed during breast cancer surgery to see whether the tissue's edges contain cancer. The current standard of practice is to remove the breast tumor tissue and send the tissue to the lab for analysis following surgery. One in five women (in the US) must later return for a second surgery to remove cancer cells that the lab found remaining in the tissue. In this study, researchers hope that the new SLI system may detect the cancer cells in the tissue's edges by imaging at the time of surgery. If successful, in the future we may use this system to improve entire cancer removal at the time of surgery, and reduce the need to perform a second surgery to remove additional breast tissue.

Detailed description

On the day of surgery, the surgeon will remove the patient's cancerous tissue, and then in a separate room near the operating room, imaging staff will test it with the Structured Light Imaging system. The testing may take several extra minutes to capture the images. After this imaging, the surgeon will complete the surgery. Following surgery, and per routine medical care, the patient's breast tumor tissue sample will be sent to DHMC's lab for testing. The patient will see her primary doctor for standard surgery follow-up. No additional imaging or testing will be required for this research study following the usual surgery.

Conditions

Interventions

TypeNameDescription
OTHERStructured Light Imaging (SLI) SystemInvestigation of SLI and Tomographic Imaging to see if they will identify cancer cells at the edge of tissue specimens removed during the operation.

Timeline

Start date
2020-02-06
Primary completion
2022-03-16
Completion
2022-03-16
First posted
2020-02-06
Last updated
2022-06-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04257799. Inclusion in this directory is not an endorsement.